Tests a quit-smoking program in pregnant women to see effects on infant weight
Tests a smoking cessation program in pregnant women who smoke, tracking infant weight gain.
Key facts
- Who runs it
- State University of New York at Buffalo
- Where
- Buffalo, United StatesSee the site
- Trial code
- Registry title
- Maternal Smoking Cessation and Pediatric Obesity Prevention
- Status
- Recruiting
- People taking part
- 48 people, planned
- Started
- 1 Jul 2015
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Multicomponent behavioral intervention
- Education only control
- Record updated
- 30 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women who smoke, are under 20 weeks pregnant, and are willing to try to quit or cut down. They need a low income and/or low education level.
- Age
- 18-39 years old
- Sex
- Women only
- Disease stage
- Singleton pregnancy, less than 20 weeks of gestation, currently smoking one or more cigarettes per day
- Biomarker or test result
- Urine cotinine test level of 1 or higher (more than 100ng/mL cotinine concentration), to confirm current smoking
Main reasons for not taking part
- History of a major chronic disease or blood clotting disorder, such as cancer, thyroid disorders, heart disease or kidney disease
- Depression, or a diagnosis of depression or post-partum depression at any time
- In treatment for Axis 1 disorders that prevent following smoking cessation interventions
This trial only enrols pregnant participants. The registry sentence this rests on: Are less than 20 weeks of gestation
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Able to read, understand, and speak English
- Are 18-39 years old
- Are less than 20 weeks of gestation
- Have a singleton pregnancy
- Currently smoking one or more cigarettes per day, based on self-report
- Currently smoking biochemically verified by a level of 1 or higher in urine cotinine test (i.e., >100ng/mL cotinine concentration)
- Willing to try to quit or reduce smoking by behavioral intervention
- Willing to monitor smoking status by breath carbon monoxide and saliva cotinine
- Willing to provide breath, saliva, and urine samples to test smoking status
- With low household income (meeting federal income eligibility guidelines for the Special Supplemental Nutrition Program for Women, Infants, and Children) and/or low education level (≤12 years). These disadvantaged pregnant women are very likely not to quit spontaneously, and thus need extra intervention most
- Currently living in Erie County or Niagara County; don't plan to move out of these two counties during the current pregnancy
Who cannot take part
- Previous history of major chronic disease or blood clotting disorders such as cancer, thyroid disorders, heart disease, kidney disease
- In treatment for Axis 1 disorders that prevent them following smoking cessation interventions
- Depression or have been diagnosed with depression or post-partum depression at any time
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 39 years old?
Where in United States
- Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at BuffaloBuffalo, United StatesContact: Xiaozhong WenTaking people
About the trial
What the trial wants to find out
The objective of this study is to test the effect of smoking cessation in pregnancy or in lactation on preventing rapid infant adiposity gain. Investigators propose a randomized, controlled experiment among smoking pregnant women from 1st prenatal care visit through 6 months of postpartum period. Two-phase randomization will be applied to separate the effects of smoking cessation in two different critical periods (i.e., pregnancy and lactation) on infant adiposity gain. Investigators will first randomly assign 40 smoking pregnant women into either the multicomponent intervention (N=30) or the education-only control group (N=10). The multicomponent intervention group will receive education and counseling, monitoring and feedback, contingent financial incentives, and family support, while the control group will receive education only. At the end of pregnancy, investigators will further randomize successful quitters (estimated N=20) from the multi-component intervention group into either the continuous multi-component intervention group in lactation (N=10) or the education-only control group (N=10). All women and their newborns will be followed from enrollment to 6 months postpartum. The key outcomes include maternal smoking abstinence confirmed by urine-cotinine and infant gain in weight-for-length z-score. Specific Aim 1 is to examine the effects of maternal smoking cessation intervention in pregnancy on infant gain in weight-for-length z-score from birth to 6 months. Specific Aim 2 is to examine the effect of maternal smoking abstinence intervention in lactation and infant post-weaning gain in weight-for-length z-score among the women who have successfully quit smoking in pregnancy.
The 2 groups in the trial
- Multicomponent behavioral interventionTreatment being tested
The multicomponent intervention group will receive education and counseling, monitoring and feedback, contingent financial incentives, and family support.
- ControlExisting treatment, for comparison
The control group will receive smoking cessation education only.
Treatment: Education only control
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pilot Study on Pediatric Obesity Prevention by Maternal Smoking Cessation in Pregnancy and Lactation
- Plain-language title
- Tests a quit-smoking program in pregnant women to see effects on infant weightGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT03514602, who can take part
- Record updated
- 30 July 2026